Le Lézard
Classified in: Health, Science and technology
Subject: IPO

Janux Therapeutics Announces Pricing of Initial Public Offering


Janux Therapeutics, Inc. (Janux), a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the pricing of its initial public offering of 11,400,000 shares of its common stock at a price to the public of $17.00 per share. The gross proceeds to Janux from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be $193.8 million. All of the shares are being offered by Janux. In addition, Janux has granted the underwriters a 30-day option to purchase up to an additional 1,710,000 shares of its common stock at the initial public offering price less the underwriting discounts and commissions.

The shares are expected to begin trading on the Nasdaq Global Market on June 11, 2021, under the ticker symbol "JANX." The offering is expected to close on June 15, 2021, subject to the satisfaction of customary closing conditions.

BofA Securities, Cowen and Evercore ISI are acting as joint book-running managers for the offering. H.C. Wainwright & Co. is acting as lead manager for the offering.

Registration statements relating to the offering of these securities have been filed with the Securities and Exchange Commission (SEC) and became effective on June 10, 2021. Copies of the registration statements can be accessed through the SEC's website at www.sec.gov. This offering is being made only by means of a written prospectus. Copies of the final prospectus relating to the initial public offering may be obtained, when available, from: BofA Securities, Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001 or by email at [email protected]; Cowen and Company, LLC, c/o Broadridge Financial Solutions, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (833) 297-2926 or by email at [email protected]; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 36th Floor, New York, NY 10055, or by telephone at (888) 474-0200 or by email at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.


These press releases may also interest you

8 fév 2025
Chef&Nutri was born out of the need to encourage healthier living. Focused on the ingestion of nutritionally complete, sustainable and functional foods, based in Bahia, the company is expanding its operations to the Southeast, Midwest and South, in...

8 fév 2025
Joint Announcement of the Teslin Tlingit Council, Government of Yukon, and Government of Canada Today, the Teslin Tlingit Council, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations and Northern Affairs, and the Government of...

8 fév 2025
On Saturday February 8th at 12 noon, the Grey Bruce, Brampton Caledon and Greater Toronto health coalitions, local chapters of the Ontario Health Coalition, will gather outside Minister of Health Sylvia Jones' constituency office to oppose and expose...

8 fév 2025
From February 6 to 9, 2025, the HICC Pet brand is showcasing its groundbreaking grooming and healthcare products at the Hong Kong Convention and Exhibition Centre during the Pet Show Hong Kong 2025. Known as a leader in pet healthcare, HICC Pet...

8 fév 2025
Report on how AI is driving market transformation - The global senior living market  size is estimated to grow by USD 130.9 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  5.8%  during the forecast...

7 fév 2025
Report with the AI impact on market trends - The global healthcare services market size is estimated to grow by USD 6.26 trillion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.73% during the forecast period....



News published on and distributed by: